Grantham Wright Dara's Insider Trades & SAST Disclosures
Grantham Wright Dara's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 502 Bio-Rad A Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Grantham Wright Dara.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | EVP, President, CDG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 502 | 2,001 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Wright Dara Grantham | EVP, President, CDG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 502 | 503 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Grantham Wright Dara | EVP, President, CDG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 306.12 per share. | 16 Dec 2023 | 174 | 1,827 (0%) | 0% | 306.1 | 53,265 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright Grantham | EVP, President, CDG | Sale of securities on an exchange or to another person at price $ 299.16 per share. | 12 Dec 2023 | 1,200 | 1,499 (0%) | 0% | 299.2 | 358,992 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 2,314 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 2,831 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 434 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 2,539 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 811 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 2,134 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 150 | 2,681 (0%) | 0% | 394.6 | 59,190 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 141 | 2,398 (0%) | 0% | 394.6 | 55,639 | Bio-Rad A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges